Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00531037 · ClinicalTrials.gov registry record
Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers
A clinical trial of Patients Implanted With a Pacemaker, sponsored by LivaNova.
- Completed
- Registry status
- 1,440
- Enrollment target
- 20
- Study locations
NCT00531037 is a study of Patients Implanted With a Pacemaker that has completed, run by LivaNova. The registered enrollment target is 1,440 participants. The trial reports 20 study locations across 7 states.
The verdict
NCT00531037, a study of Patients Implanted With a Pacemaker, has completed, sponsored by LivaNova.
- COMPLETED
- Registry status
- 1,440 participants
- Enrollment target
- 20
- Study locations
Study Summary
Observational study to assess AV block incidence and their evolution according to paroxysmal atrial arrhythmia.
Conditions Studied
Study Locations (20)
Other
- Az St- Blasius - Dendermonde
- Ch de Huy - Huy
- Heilig Hart Ziekenhuis MOL - Mol
- Hospital Hamilton - Hamilton
- Niagara Health System - Niagara
- Bispebjerg Hospital - Bispebjerg
- HELLERUP - Gentofte Hospital
- Clinique Esquirol - Agen
- CH Albi - Albi
- Clinique Claude Bernard - Albi
- CH ALES - Alès
- Clinique Bonnefond - Alès
- Cabinet Prive - Annecy
Alabama
- Baptist Princeton Birmingham - Birmingham
- Tennessee Valley Sheffield - Sheffield
Arizona
- Cardiovascular Assoc. Of Mesa - Mesa
California
- O'Connor Hospital San Jose - San Jose
Georgia
- Piedmont hospital - Piedmont
Mississippi
- University of Mississippi Medical Center - Mississippi City
Oklahoma
- St. Francis Hospital Tulsa - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,440 participants |
| Start Date | 2007-06 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00531037
The ClinicalTrials.gov registry entry for NCT00531037 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,440 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LivaNova, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patients Implanted With a Pacemaker appearing as the primary indexed condition, and to 0 interventions.
NCT00531037 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Other, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00531037 about?
NCT00531037 is a clinical study titled "Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers". Observational study to assess AV block incidence and their evolution according to paroxysmal atrial arrhythmia.
What is the current status of trial NCT00531037?
This trial is currently completed. The enrollment target is 1,440 participants. The study started on 2007-06. Estimated completion is 2011-12.
What conditions does trial NCT00531037 study?
This clinical trial studies the following conditions: Patients Implanted With a Pacemaker.
Who is sponsoring clinical trial NCT00531037?
This trial is sponsored by LivaNova, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00531037 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Georgia, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.